SCHEMBL8239678

SCHEMBL8239678

C=C(c1cccnc1)N1CCN(c2ccc(Nc3nccc(-c4ccc(NC(=O)CN(C)C)cc4)n3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 18/20 0.53
HDAC1 Q13547 5/20 0.53
HDAC6 Q9UBN7 4/20 0.53
JAK3 P52333 12/20 0.51
JAK1 P23458 7/20 0.51
CDK2 P24941 2/20 0.51
TYK2 P29597 4/20 0.50
HDAC3 O15379 1/20 0.47
NCOR1 O75376 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
ACVR1 Q04771 2/20 0.47
BMPR1B O00238 1/20 0.46
PLK4 O00444 1/20 0.46
CIT O14578 1/20 0.46
GAK O14976 1/20 0.46
OPA1 O60313 1/20 0.46
ROCK2 O75116 1/20 0.46
STK16 O75716 1/20 0.46
PRKD3 O94806 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4386914 0.92 JAK2 (0.55) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4388668 0.85 CDK2 (0.64) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4378420 0.84 JAK2 (0.58) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4377681 0.83 JAK2 (0.59) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4385539 0.83 JAK2 (0.59) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4382104 0.83 JAK2 (0.57) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4377370 0.82 JAK2 (0.58) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4379589 0.82 JAK2 (0.62) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4377714 0.82 JAK2 (0.75) JAK2HDAC1HDAC6JAK3JAK1
SCHEMBL4379946 0.82 JAK2 (0.62) JAK2HDAC1HDAC6JAK3JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007089768-A2 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM EXELIXIS, INC. (US) 2007-08-09 WO disclosed